RxRevu Raises $15.9M in Series A Funding

RxRevuRxRevu, a Denver, CO-based Prescription Decision Support company, raised $15.9m in Series A funding.

The round was led by Colorado-based nonprofit health system UCHealth, with participation from University of Virginia LVG Venture Fund, Presbyterian Healthcare Services (NM), Inception Health/Froedtert Health, Children’s Hospital Colorado, UnityPoint Health, JAZZ Venture Partners and existing investors.
In conjunction with the funding, Toby Cosgrove, M.D., executive advisor at Cleveland Clinic, and Richard Zane, M.D., chief innovation officer at UCHealth, have joined the RxRevu Board of Directors.

The company intends to use the funds for continued growth.

Led by Carm Huntress, co-founder and CEO, RxRevu provides a platform and a suite of Prescription Decision Support tools, which allow healthcare professionals to make more informed prescribing decisions by considering everything from a patient’s medical history and individual insurance coverage to the cost that patients will pay today at their favorite pharmacy and enable health systems to holistically manage and measure clinicians prescribing performance.



Join the discussion